E-Mail:
Password:
Home | Stock Market Blogs | Financial Tools | Sign Up Free
 

gear headHow cool is this? Shampoo for men in a quart of oil bottle!

Click the banner to get some now and tell the little lady to throw that other stuff in the trash!
Brainstorm Cell Therapeutics, Inc.  
Brainstorm Cell Therapeutics, Inc.
BCLILast: $0.19 ($-0.01)Volume: 130,871Last Trade: 8/5/2010 5:20:02 PM
Today

Today | Last 7 Days | 1 Month | 3 Month | 6 Month | 1 Year
 Options
Quote |  Alerts | | Free Newsletter
 
 Detailed Quote
OTC PK:BCLI $0.19 ($-0.01 -5.0%)
Industry: Bio-Technology Sector: Conglomerates
Open: 0.20 Previous Close: 0.20
Day's High: 0.20 Day's Low: 0.19
52-Week High: 1.15 52-Week Low: 0.26
 
Bid: 0.15 / 5,000 Ask: 0.20 / 5,000
Volume: 130,871 Outstanding: 0
Market Cap: -
Brainstorm Cell Therapeutics, Inc. Profile
Brainstorm Cell Therapeutics, Inc. develops NurOwn cell therapy products sourced from adult stem cells for treatment of neurodegenerative diseases. It primarily focuses on the development of bone marrow derived neural-like cells for Parkinson's disease. Brainstorm Cell Therapeutics is also developing embryonic stem cells and adult stem cells for multiple cell therapy products. The company was incorporated in 2000 under the name Wizbang Technologies, Inc. and changed its name to Golden Hand Resources, Inc. in 2003.
 Brainstorm Cell Therapeutics, Inc. News & Press Releases

BrainStorm To Present At World Stem Cells and Regenerative Medicine Congress
BrainStorm Cell Therapeutics Inc. ( BCLI ), a leading developer of adult stem cell technologies and therapeutics is pleased to announce that Dr. Avinoam Kadour... [more]



World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brow
Brainstorm Cell Therapeutics Inc. ( BCLI ), a leading developer of adult stem cell technologies and therapeutics, announced today that world renowned ALS medic... [more]

BrainStorm Cell Therapeutics NTF Cells Shows Significant Advantage in Pre-Clinical Study for Parkins
BrainStorm Cell Therapeutics Inc. ( BCLI ), a leading developer of adult stem cell technologies and therapeutics, announced today that in a pre-clinical study... [more]

Brainstorm Cell Therapeutics Chief Scientist, Dr. Daniel Offen, To Present Results from New Parkinso
BrainStorm Cell Therapeutics Inc. ( BCLI ), a leading developer of adult stem cell technologies and therapeutics, announced today that Dr. Daniel Offen, the Co... [more]


Home | Blogs | Savings Calculator | Tools | Contact Us | Disclosure | Site Map | Sign UpCopyright 2014
SmallCapWatch, LLC.
Never invest based soley on information from this website or our e-mail and IM alerts